Pirtobrutinib: a new hope for patients with BTK inhibitor-refractory lymphoproliferative disorders. Thompson PA, Tam CS. Blood 2023;141:3137-3142.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thompson PA, Tam CS. Pirtobrutinib: a new hope for patients with BTK inhibitor-refractory lymphoproliferative disorders. Blood 2023;141:3137-3142.
PMID: 37156004